TAMIR BIOTECHNOLOGY, INC. THIRD AMENDMENT TO INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • December 19th, 2012 • Tamir Biotechnology, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledDecember 19th, 2012 Company Industry JurisdictionThis Third Amendment (this “Amendment”) to Investor Rights Agreement dated as of October 19, 2009 (the “Agreement”), is entered into as of the 11th day of December, 2012, by and among TAMIR BIOTECHNOLOGY, INC., a Delaware corporation (the “Company”) and the “Holders” party hereto. Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Agreement.
TAMIR BIOTECHNOLOGY, INC. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 19th, 2012 • Tamir Biotechnology, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledDecember 19th, 2012 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is made and entered into as of December 11, 2012, by and among Tamir Biotechnology, Inc., a Delaware corporation (the “Company”), and the investors identified on the signature pages hereto (each, a “Purchaser”, and collectively, the “Purchasers”).